Loading…
Nephro Care India (NEPHROCARE)₹79.95+3.03%Hospital
Nephro Care India is compared with the 10 closest in size in Hospital (41 companies in the industry). It has a P/E of 39.0 against a peer median of 32.8, and ROCE of 8.4% against a peer median of 8.4%, and latest-quarter sales growth of 68.6% against a peer median of 22.5%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Hospital
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asarfi Hospital | 352 | 19.7 | 19.0 | 18.6 | 0.54 | 0.0 | 175 | 17 | 33.2 | 37.0 | vs NEPHROCARE |
| Hannah Joseph Hospital | 250 | 22.3 | 17.9 | 15.1 | 0.28 | 1.8 | 92 | 11 | 35.0 | 100.0 | vs NEPHROCARE |
| Aashka Hospitals | 224 | 67.5 | 4.0 | 2.8 | 0.08 | 0.0 | 23 | 3 | 22.2 | 53.6 | vs NEPHROCARE |
| Lotus Eye Hospital and Institute | 208 | 1,429.3 | 1.2 | 0.1 | 0.26 | 0.0 | 54 | 0 | 26.2 | 12.7 | vs NEPHROCARE |
| Nephro Care India | 132 | 39.0 | 8.4 | 5.9 | 0.00 | 0.0 | 88 | 3 | 68.6 | — | — |
| Abate As Industries | 121 | 9.4 | 7.0 | 5.1 | 0.06 | 0.0 | 159 | 12 | −44.4 | −0.4 | vs NEPHROCARE |
| Fortis Malar Hospitals | 84 | 898.0 | 14.7 | 12.8 | 0.00 | 0.0 | 0 | 4 | −100.0 | −96.6 | vs NEPHROCARE |
| Sangani Hospitals | 80 | 26.6 | 17.0 | 7.8 | 0.04 | 0.0 | 107 | 4 | 682.1 | 198.0 | vs NEPHROCARE |
| Maitreya Medicare | 80 | — | −1.9 | −9.4 | 0.80 | 0.0 | 42 | −2 | −0.0 | — | vs NEPHROCARE |
| Shanmuga Hospital | 61 | 14.6 | 12.7 | 10.2 | 0.16 | 0.0 | 47 | 4 | −1.9 | 21.7 | vs NEPHROCARE |
| Aatmaj Healthcare | 57 | 78.1 | 3.6 | 1.4 | 0.41 | 0.0 | 24 | 1 | 22.5 | −38.2 | vs NEPHROCARE |
| Peer median | 121 | 32.8 | 8.4 | 5.9 | 0.16 | 0.0 | 54 | 4 | 22.5 | 21.7 |
Listed companies closest to Nephro Care India in Hospital include Asarfi Hospital, Hannah Joseph Hospital, Aashka Hospitals, Lotus Eye Hospital and Institute, Abate As Industries, Fortis Malar Hospitals, Sangani Hospitals, Maitreya Medicare.
Asarfi Hospital, with a market cap of ₹352 Cr.
Nephro Care India trades at a P/E of 39.0; the median of its peer set is 32.8. A P/E above or below the median is a description, not a judgement on value.
Nephro Care India's return on capital employed is 8.4%, above the peer median of 8.4%.